APA (7th ed.) Citation

WT, K., KY, C., HM, L., & Y, C. (2026). Glucagon-Like Peptide 1 Receptor Agonist Use and Vertebral Fracture Risk in Type 2 Diabetes. JAMA surgery, 161(2), 197. https://doi.org/10.1001/jamasurg.2025.5372

Chicago Style (17th ed.) Citation

WT, Khor, Chi KY, Lin HM, and Chang Y. "Glucagon-Like Peptide 1 Receptor Agonist Use and Vertebral Fracture Risk in Type 2 Diabetes." JAMA Surgery 161, no. 2 (2026): 197. https://doi.org/10.1001/jamasurg.2025.5372.

MLA (9th ed.) Citation

WT, Khor, et al. "Glucagon-Like Peptide 1 Receptor Agonist Use and Vertebral Fracture Risk in Type 2 Diabetes." JAMA Surgery, vol. 161, no. 2, 2026, p. 197, https://doi.org/10.1001/jamasurg.2025.5372.